Tender detail
Medical laboratory services
Summary
The tender concerns a framework agreement for next-generation sequencing of a myeloid 56-gene panel in blood samples, including bioinformatic analysis and evaluation. The estimated volume is about 50–500 blood samples per year. The machine-readable notice did not include precise qualification, exclusion or compliance requirements; these must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.